Orange Book product · Generic (ANDA)
METHYLERGONOVINE MALEATE
METHYLERGONOVINE MALEATE
At a glance
Nov 24, 2008
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 24, 2008
17 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
METHYLERGONOVINE MALEATE
Strength
0.2MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 090193
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of METHYLERGONOVINE MALEATE
- —METHERGINEBrand (NDA)
NDA 006035 · EDISON THERAPS LLC
- 2021METHYLERGONOVINE MALEATEGeneric (ANDA)
ANDA 211919 · RISING
- 2020METHYLERGONOVINE MALEATEGeneric (ANDA)
ANDA 212233 · TP ANDA HOLDINGS
- 2019METHYLERGONOVINE MALEATEGeneric (ANDA)
ANDA 211455 · TEVA PHARMS USA
- 2018METHYLERGONOVINE MALEATEGeneric (ANDA)
ANDA 211483 · AMNEAL PHARMS
- 2018METHYLERGONOVINE MALEATEGeneric (ANDA)
ANDA 210424 · GRANULES
- 2011METHYLERGONOVINE MALEATEGeneric (ANDA)
ANDA 091577 · CHARTWELL RX
- 2010METHYLERGONOVINE MALEATEGeneric (ANDA)
ANDA 040889 · BRECKENRIDGE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
